Synthesis of truncated analogues of ProTx-II as a novel form of pain relief

Chronic pain affects almost 10 million people in the UK but despite this, few effective treatments exist. Research has shown that targeting the Nav1.7 ion channel provides a novel approach to treatment. ProTx-II, a 30 amino acid peptide isolated from Tarantula venom, is highly selective for the chan...

Full description

Bibliographic Details
Main Author: Wright, Z. V. F.
Published: University College London (University of London) 2015
Subjects:
540
Online Access:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.654707
id ndltd-bl.uk-oai-ethos.bl.uk-654707
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-6547072016-08-04T03:28:12ZSynthesis of truncated analogues of ProTx-II as a novel form of pain reliefWright, Z. V. F.2015Chronic pain affects almost 10 million people in the UK but despite this, few effective treatments exist. Research has shown that targeting the Nav1.7 ion channel provides a novel approach to treatment. ProTx-II, a 30 amino acid peptide isolated from Tarantula venom, is highly selective for the channel (IC50 value - 0.3nm in vitro) but in vivo results were less promising. ProTx-II contains three interlocking disulfide bonds connected in a distinctive pattern. To investigate the structure-activity relationship between the peptide and the ion channel, truncated analogues based on the individual cysteine rings were synthesised. This thesis investigates the effect of replacing the disulfide bond with a thioether linkage through the incorporation of a novel diastereoisomer of the non-natural amino acid lanthionine to produce hydrolytically stable compounds. Lanthionine can be thought of as two alanine residues connected by a thioether linkage at the β-carbon. Improvements in the synthesis allowed for the first large scale production of lanthionine enabling multiple attempts at peptide synthesis to be carried out. Work was also begun on the synthesis of cystathionine, a second thioether linker containing an extra CH2 group between the amino acid centres. Novel methodologies were investigated for the incorporation of a new diastereomer of lanthionine containing two L-amino acid centres using a new microwave-based methodology. This methodology has so far produced the largest known synthetic rings containing a lanthionine bridge, along with the first interlocking disulfide and thioether bridged compounds. The analogues produced were modelled using in silico mutagenesis techniques and the effect of these analogues on the hNav1.7 receptor was investigated using an automated patch clamp assay. Finally, analysis of the connectivity of ProTx-II was carried out using a combination of digestion and MS/MS experiments.540University College London (University of London)http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.654707http://discovery.ucl.ac.uk/1467249/Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 540
spellingShingle 540
Wright, Z. V. F.
Synthesis of truncated analogues of ProTx-II as a novel form of pain relief
description Chronic pain affects almost 10 million people in the UK but despite this, few effective treatments exist. Research has shown that targeting the Nav1.7 ion channel provides a novel approach to treatment. ProTx-II, a 30 amino acid peptide isolated from Tarantula venom, is highly selective for the channel (IC50 value - 0.3nm in vitro) but in vivo results were less promising. ProTx-II contains three interlocking disulfide bonds connected in a distinctive pattern. To investigate the structure-activity relationship between the peptide and the ion channel, truncated analogues based on the individual cysteine rings were synthesised. This thesis investigates the effect of replacing the disulfide bond with a thioether linkage through the incorporation of a novel diastereoisomer of the non-natural amino acid lanthionine to produce hydrolytically stable compounds. Lanthionine can be thought of as two alanine residues connected by a thioether linkage at the β-carbon. Improvements in the synthesis allowed for the first large scale production of lanthionine enabling multiple attempts at peptide synthesis to be carried out. Work was also begun on the synthesis of cystathionine, a second thioether linker containing an extra CH2 group between the amino acid centres. Novel methodologies were investigated for the incorporation of a new diastereomer of lanthionine containing two L-amino acid centres using a new microwave-based methodology. This methodology has so far produced the largest known synthetic rings containing a lanthionine bridge, along with the first interlocking disulfide and thioether bridged compounds. The analogues produced were modelled using in silico mutagenesis techniques and the effect of these analogues on the hNav1.7 receptor was investigated using an automated patch clamp assay. Finally, analysis of the connectivity of ProTx-II was carried out using a combination of digestion and MS/MS experiments.
author Wright, Z. V. F.
author_facet Wright, Z. V. F.
author_sort Wright, Z. V. F.
title Synthesis of truncated analogues of ProTx-II as a novel form of pain relief
title_short Synthesis of truncated analogues of ProTx-II as a novel form of pain relief
title_full Synthesis of truncated analogues of ProTx-II as a novel form of pain relief
title_fullStr Synthesis of truncated analogues of ProTx-II as a novel form of pain relief
title_full_unstemmed Synthesis of truncated analogues of ProTx-II as a novel form of pain relief
title_sort synthesis of truncated analogues of protx-ii as a novel form of pain relief
publisher University College London (University of London)
publishDate 2015
url http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.654707
work_keys_str_mv AT wrightzvf synthesisoftruncatedanaloguesofprotxiiasanovelformofpainrelief
_version_ 1718369465441189888